{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:46:35Z","timestamp":1792446395378,"version":"4.5.0"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/cad.0b013e3283650bda","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T12:19:33Z","timestamp":1377001173000},"page":"1007-1019","source":"Crossref","is-referenced-by-count":128,"title":["Platinum compounds in children with cancer"],"prefix":"10.1097","volume":"24","author":[{"given":"Antonio","family":"Ruggiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Trombatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Triarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Scalzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210203","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.","volume":"23","author":"Knight","year":"2005","journal-title":"J Clin Oncol"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.ftd.0000198646.32128.ef","article-title":"Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.","volume":"28","author":"Mercier","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008215213739","article-title":"Carboplatin versus cisplatin in solid tumors: an analysis of the literature.","volume":"9","author":"Lokich","year":"1998","journal-title":"Ann Oncol"},{"key":"R5-3-20210203","first-page":"537","article-title":"Designing platinum compounds in cancer: structures and mechanisms.","volume":"5","author":"Boulikas","year":"2007","journal-title":"Cancer Ther"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.","volume":"17","author":"Go","year":"1999","journal-title":"J Clin Oncol"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ctrv.2011.03.005","article-title":"Cytostatic drugs in infants: a review on pharmacokinetic data in infants.","volume":"18","author":"Van den Berg","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","article-title":"Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.","volume":"34","author":"Lebwohl","year":"1998","journal-title":"Eur J Cancer"},{"key":"R12-3-20210203","first-page":"1972","article-title":"Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diam-minedi-chloroplatinum (II) and cis-diammine (1,1-cyclobutane-diacarbo-xylate) platinum (II) differ only in kinetics of their interaction with DNA.","volume":"46","author":"Knox","year":"1986","journal-title":"Cancer Res"},{"key":"R13-3-20210203","first-page":"4043","article-title":"A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum (II) and cis-diamminedichloroplatinum (II) on L1210 cells.","volume":"45","author":"Micetich","year":"1985","journal-title":"Cancer Res"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1002\/chem.200700887","article-title":"On the hydrolysis mechanism of the second-generation anticancer drug carboplatin.","volume":"13","author":"Pavelka","year":"2007","journal-title":"Chemistry"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(00)02044-4","article-title":"Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer.","volume":"355","author":"Gietema","year":"2000","journal-title":"Lancet"},{"key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2004.12.006","article-title":"Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.","volume":"31","author":"Kweekel","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"R20-3-20210203","first-page":"1021","article-title":"Activity of oxaliplatin against human tumor colony forming units.","volume":"4","author":"Raymond","year":"1998","journal-title":"Clin Cancer Res"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0959-8049(98)00342-6","article-title":"Antitumor activity of oxaliplatin in neuroblastoma cell lines.","volume":"35","author":"Riccardi","year":"1999","journal-title":"Eur J Cancer"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/bi00456a026","article-title":"Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.","volume":"29","author":"Page","year":"1990","journal-title":"Biochemistry"},{"key":"R26-3-20210203","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high frequency audiometry and evoked distortion product otoacoustic emissions.","volume":"25","author":"Knight","year":"2007","journal-title":"J Clin Oncol"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/019459989310900302","article-title":"Patterns of hearing loss resulting from cisplatinum therapy.","volume":"109","author":"Blakely","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R28-3-20210203","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/bjc.1990.208","article-title":"Ototoxicity of cisplatinum in children and adolescents.","volume":"61","author":"Skinner","year":"1990","journal-title":"Br J Cancer"},{"key":"R30-3-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","article-title":"Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.","volume":"193","author":"Dickey","year":"2004","journal-title":"Hear Res"},{"key":"R31-3-20210203","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.heares.2004.12.007","article-title":"Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs.","volume":"203","author":"Van Ruijven","year":"2005","journal-title":"Hear Res"},{"key":"R32-3-20210203","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ar.22577","article-title":"Ototoxic characteristics of platinum antitumor drugs.","volume":"295","author":"Ding","year":"2012","journal-title":"Anat Rec"},{"key":"R33-3-20210203","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3109\/00016480902856604","article-title":"Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice.","volume":"129","author":"He","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"R34-3-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5955(90)90046-R","article-title":"Interaction of cisplatin and noise on the peripheral auditory system.","volume":"50","author":"Gratton","year":"1990","journal-title":"Hear Res"},{"key":"R35-3-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)04090-8","article-title":"Upregulated iNOS and oxidative damage to the cochlear stria vascularis due to noise stress.","volume":"967","author":"Shi","year":"2003","journal-title":"Brain Res"},{"key":"R36-3-20210203","first-page":"158","article-title":"Dose-dependent inner ear changes after i.v. administration of cisplatin.","volume":"20","author":"Laurell","year":"1991","journal-title":"J Otolaryngol"},{"key":"R37-3-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention.","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear Res"},{"key":"R38-3-20210203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000099020","article-title":"Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.","volume":"12","author":"Laurell","year":"2007","journal-title":"Audiol Neurootol"},{"key":"R39-3-20210203","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(03)00142-4","article-title":"Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage.","volume":"182","author":"Sergi","year":"2003","journal-title":"Hear Res"},{"key":"R40-3-20210203","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level.","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol Rep"},{"key":"R43-3-20210203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pbc.21155","article-title":"A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.","volume":"50","author":"Lambert","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R44-3-20210203","first-page":"88","article-title":"Carboplatin versus cisplatin in ovarian cancer.","volume":"22","author":"Alberts","year":"1995","journal-title":"Semin Oncol"},{"key":"R47-3-20210203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPH.0b013e31815d1d83","article-title":"Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.","volume":"30","author":"Dean","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R50-3-20210203","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/pbc.20036","article-title":"Ototoxicity following pediatric hematopoietic stem cell transplantation: a prospective cohort study.","volume":"42","author":"Punnett","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R52-3-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/S0022215100123771","article-title":"Carboplatin ototoxicity: an animal model.","volume":"107","author":"Wake","year":"1993","journal-title":"J Laryngol Otol"},{"key":"R53-3-20210203","first-page":"97","article-title":"Induction of selective inner hair cell damage by carboplatin.","volume":"8","author":"Takeno","year":"1994","journal-title":"Scanning Microsc"},{"key":"R54-3-20210203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/00206099709071981","article-title":"Magnitude and pattern of inner and outer hair cell loss in chinchilla as a function of carboplatin dose.","volume":"36","author":"Hofstetter","year":"1997","journal-title":"Audiology"},{"key":"R55-3-20210203","first-page":"191","article-title":"Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis.","volume":"120","author":"Zhang","year":"2003","journal-title":"J Neurosci Res"},{"key":"R56-3-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1672-2930(08)50018-3","article-title":"Spontaneous proliferation in organotypic cultures of mouse cochlea.","volume":"3","author":"Ding","year":"2008","journal-title":"J Otol"},{"key":"R59-3-20210203","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/014556131008900607","article-title":"Acute ototoxicity from a single infusion of oxaliplatin.","volume":"89","author":"Malhotra","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"R60-3-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system.","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"R61-3-20210203","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1542\/peds.2009-1597","article-title":"Auditory late effects of childhood cancer therapy: a report from the childrens oncology group.","volume":"125","author":"Grewal","year":"2010","journal-title":"Pediatrics"},{"key":"R62-3-20210203","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cncr.22004","article-title":"Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.","volume":"107","author":"Kushner","year":"2006","journal-title":"Cancer"},{"key":"R63-3-20210203","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.2009.26.7872","article-title":"Critical need for international consensus on ototoxicity assessment criteria editorial.","volume":"28","author":"Neuwelt","year":"2010","journal-title":"J Clin Oncol"},{"key":"R64-3-20210203","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2011.41.3187","article-title":"New International Society of Pediatric Oncology Boston ototoxicity grading scale for pediatric oncology: still room for improvement editorial.","volume":"30","author":"Gurney","year":"2012","journal-title":"J Clin Oncol"},{"key":"R66-3-20210203","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1200\/JCO.2009.24.4228","article-title":"Practical grading system for evaluating cisplatin ototoxicity in children.","volume":"28","author":"Chang","year":"2010","journal-title":"J Clin Oncol"},{"key":"R67-3-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.heares.2004.07.016","article-title":"Antioxidant protection in a new animal model of cisplatin-induced ototoxicity.","volume":"198","author":"Minami","year":"2004","journal-title":"Hear Res"},{"key":"R68-3-20210203","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/jpet.105.087601","article-title":"Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.","volume":"314","author":"Dickey","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R69-3-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-007-0597-2","article-title":"Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.","volume":"62","author":"Dickey","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"R70-3-20210203","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00405-006-0070-6","article-title":"Cisplatin ototoxicity and otoprotection with sodium salicylate.","volume":"263","author":"Hyppolito","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R72-3-20210203","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/00005537-199911000-00003","article-title":"Application of antioxidants and other agents to prevent cisplatin ototoxicity.","volume":"109","author":"Rybak","year":"1999","journal-title":"Laryngoscope"},{"key":"R73-3-20210203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2310\/7070.2003.11264","article-title":"Assessment of the protective effects of amifostine against cisplatin-induced toxicity.","volume":"32","author":"Hussain","year":"2003","journal-title":"J Otolaryngol"},{"key":"R78-3-20210203","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00005537-200403000-00028","article-title":"Vitamin E reduces cisplatin ototoxicity.","volume":"114","author":"Kalkanis","year":"2004","journal-title":"Laryngoscope"},{"key":"R79-3-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mhn.2002.125299","article-title":"Round window application of D-methionine provides complete cisplatin otoprotection.","volume":"126","author":"Korver","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R80-3-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00129492-200401000-00007","article-title":"Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity.","volume":"25","author":"Wimmer","year":"2004","journal-title":"Otol Neurotol"},{"key":"R83-3-20210203","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.","volume":"40","author":"Li","year":"2004","journal-title":"Eur J Cancer"},{"key":"R86-3-20210203","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R87-3-20210203","first-page":"191","article-title":"Cisplatin and cranial irradiation-related hearing loss in children.","volume":"12","author":"Warrier","year":"2012","journal-title":"Ochsner J"},{"key":"R91-3-20210203","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1288\/00005537-198507000-00014","article-title":"Delayed effects of ionizing radiation on the ear.","volume":"95","author":"Bohne","year":"1985","journal-title":"Laryngoscope"},{"key":"R93-3-20210203","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2008.01.050","article-title":"Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.","volume":"72","author":"Hua","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R94-3-20210203","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00016489709124092","article-title":"Radiotherapy enhanced ototoxicity of cisplatin in children.","volume":"529","author":"Miettinen","year":"1997","journal-title":"Acta Otolaryngol Suppl"},{"key":"R95-3-20210203","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1200\/JCO.1990.8.7.1191","article-title":"Ototoxicity of preradiation cisplatin for children with central nervous system tumors.","volume":"8","author":"Kretschmar","year":"1990","journal-title":"J Clin Oncol"},{"key":"R98-3-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pbc.21530","article-title":"Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.","volume":"51","author":"Merchant","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R99-3-20210203","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/bmj.39301.680266.AE","article-title":"Ototoxicity caused by aminoglycosides.","volume":"335","author":"Bitner-Glindzicz","year":"2007","journal-title":"BMJ"},{"key":"R102-3-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000421-199906000-00020","article-title":"Cisplatin ototoxicity: the importance of baseline audiometry.","volume":"22","author":"Nagy","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"R103-3-20210203","first-page":"6502","article-title":"Prospective of validation of a pharmacologically-based dosing scheme for the cis-diamminedichloroplatin (II) analogue cis-diammine-cyclobutanedicarboxylato platinum (II).","volume":"45","author":"Egorin","year":"1985","journal-title":"Cancer Res"},{"key":"R104-3-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/bjc.1982.216","article-title":"Effects of cisplatin on different haemopoietic progenitor cells in mice.","volume":"46","author":"Nowrousian","year":"1982","journal-title":"Br J Cancer"},{"key":"R105-3-20210203","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1056\/NEJM198102053040618","article-title":"Cisplatin toxicity for erythroid precursors.","volume":"304","author":"Rothmann","year":"1981","journal-title":"N Engl J Med"},{"key":"R106-3-20210203","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1136\/bmj.282.6281.2003","article-title":"Haemolytic anaemia after cisplatin treatment.","volume":"282","author":"Levi","year":"1981","journal-title":"Br Med J"},{"key":"R108-3-20210203","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity.","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"R109-3-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review.","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"R111-3-20210203","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R112-3-20210203","first-page":"5925","article-title":"Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.","volume":"54","author":"Hanigan","year":"1994","journal-title":"Cancer Res"},{"key":"R114-3-20210203","first-page":"700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis.","volume":"270","author":"Lieberthal","year":"1996","journal-title":"Am J Physiol"},{"key":"R115-3-20210203","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.","volume":"110","author":"Ramesh","year":"2002","journal-title":"J Clin Invest"},{"key":"R117-3-20210203","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fct.2006.01.013","article-title":"Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.","volume":"44","author":"Ali","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"R118-3-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.1993.1184","article-title":"Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.","volume":"50","author":"Cornelison","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R119-3-20210203","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity.","volume":"23","author":"Arany","year":"2003","journal-title":"Semin Nephrol"},{"key":"R120-3-20210203","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.","volume":"61","author":"Launay-Vacher","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"R121-3-20210203","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","article-title":"Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.","volume":"45","author":"Skinner","year":"2009","journal-title":"Eur J Cancer"},{"key":"R123-3-20210203","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s004670100610","article-title":"Cisplatin nephrotoxicity in children after continuous 72-h and 31-h infusions.","volume":"16","author":"Erdlenbruch","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"R124-3-20210203","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1345\/aph.1Q333","article-title":"The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.","volume":"46","author":"Morgan","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R125-3-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/bjc.1986.147","article-title":"Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial.","volume":"54","author":"Willox","year":"1986","journal-title":"Br J Cancer"},{"key":"R126-3-20210203","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","article-title":"Renal late effects in patients treated for cancer in childhood: a report from the Childrens Oncology Group.","volume":"51","author":"Jones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R127-3-20210203","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6690697","article-title":"Dose-related nephrotoxicity of carboplatin in children.","volume":"81","author":"English","year":"1999","journal-title":"Br J Cancer"},{"key":"R128-3-20210203","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0959-8049(92)90508-Y","article-title":"Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.","volume":"28","author":"Gordon","year":"1992","journal-title":"Eur J Cancer"},{"key":"R129-3-20210203","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/annonc\/mdm080","article-title":"Renal tubular acidosis due to oxaliplatin.","volume":"18","author":"Linch","year":"2007","journal-title":"Ann Oncol"},{"key":"R130-3-20210203","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding.","volume":"27","author":"Ta","year":"2006","journal-title":"Neurotoxicology"},{"key":"R132-3-20210203","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/nar\/gkm032","article-title":"Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.","volume":"35","author":"Chvalova","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"R133-3-20210203","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1021\/jp0518916","article-title":"Hydrolysis process of the second generation platinum-based anticancer drug cis-amminedichlorocyclohexylamineplatinum (II).","volume":"109","author":"Zhu","year":"2005","journal-title":"J Phys Chem B"},{"key":"R134-3-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics.","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R135-3-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp.64.5.667","article-title":"Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy.","volume":"64","author":"Heinzlef","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R136-3-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0959-8049(01)00381-1","article-title":"Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity.","volume":"38","author":"Van den Bent","year":"2002","journal-title":"Eur J Cancer"},{"key":"R137-3-20210203","first-page":"843019","article-title":"Neurotoxicity caused by the treatment with platinum analogues.","volume":"2011","author":"Amptoulach","year":"2011","journal-title":"Chemother Res Pract"},{"key":"R138-3-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0360-3016(94)90565-7","article-title":"Protective effects of glutathione on cisplatin neurotoxicity in rats.","volume":"29","author":"Cavaletti","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R140-3-20210203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00165711","article-title":"Enhanced cis-platinum neurotoxicity in pediatric patients with brain tumors.","volume":"1","author":"Granowetter","year":"1983","journal-title":"J Neurooncol"},{"key":"R141-3-20210203","doi-asserted-by":"crossref","first-page":"201593","DOI":"10.1155\/2011\/201593","article-title":"Oxaliplatin-induced neuropathy in colorectal cancer.","volume":"2011","author":"Weickhardt","year":"2011","journal-title":"J Oncol"},{"key":"R146-3-20210203","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/028418600750013447","article-title":"Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.","volume":"39","author":"Gerl","year":"2000","journal-title":"Acta Oncol"},{"key":"R147-3-20210203","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2011.37.4025","article-title":"Impact of long-term serum platinum concentrations on neuro- and oto-toxicity in cisplatin-treated survivors of testicular cancer.","volume":"3","author":"Sprauten","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e3283650bda","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:18:45Z","timestamp":1620947925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201311000-00003"}},"subtitle":["toxicity and clinical management"],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3283650bda","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}